Scripps Altering Its Deal With Sandoz: The nation's largest independent biomedical research institute said it is reworking a contract with the pharmaceutical company to reduce the control the Swiss drug maker will have over the research center. La Jolla-based Scripps announced the change after its proposed affiliation with Sandoz was attacked in congressional hearings as amounting to a foreign buyout. Scripps Research Institute gets about $70 million of its $120-million annual budget from federal grants. Under last year's plan, Scripps would grant Sandoz right of first refusal to commercialize all its discoveries over 10 years.
From Times Staff and Wire Reports
Copyright © 2019, Los Angeles Times